These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37270801)

  • 1. Updates in Immunohistochemistry for Hematopoietic and Lymphoid Neoplasms.
    Kavus H; Ding Y; Dhesi M
    Arch Pathol Lab Med; 2024 Mar; 148(3):292-298. PubMed ID: 37270801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing Lymphoma on Core Needle Biopsy and the Challenging Role of Immunohistochemistry.
    Al-Maghrabi H
    Cureus; 2023 Dec; 15(12):e49983. PubMed ID: 38179383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma.
    Zhang XM; Aguilera N
    Arch Pathol Lab Med; 2014 Dec; 138(12):1666-72. PubMed ID: 25427044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma.
    Higgins RA; Blankenship JE; Kinney MC
    Arch Pathol Lab Med; 2008 Mar; 132(3):441-61. PubMed ID: 18318586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practices in diagnostic immunohistochemistry: workup of cutaneous lymphoid lesions in the diagnosis of primary cutaneous lymphoma.
    Dewar R; Andea AA; Guitart J; Arber DA; Weiss LM
    Arch Pathol Lab Med; 2015 Mar; 139(3):338-50. PubMed ID: 25724031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who is WHO and what was REAL?
    Cogliatti SB; Schmid U
    Swiss Med Wkly; 2002 Dec; 132(43-44):607-17. PubMed ID: 12587044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic study of 369 B-cell non-Hodgkin lymphoma cases, with reference to the 2001 World Health Organization classification of lymphoid neoplasms].
    Zhang YN; Zhou XG; Zhang SH; Wang P; Zhang CH; Huang SF
    Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):193-7. PubMed ID: 16091170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of proliferative lesions of haematopoietic and lymphoid tissue in the female productive tract].
    Chen DB; Zhang H; Zhang YH; Wang Y; Song QJ; Yang SM; Cui H; Zhao Y; Fang XZ; Shen DH
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):263-269. PubMed ID: 29747272
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostically relevant updates to the 2017 WHO classification of lymphoid neoplasms.
    Choi SM; O'Malley DP
    Ann Diagn Pathol; 2018 Dec; 37():67-74. PubMed ID: 30308438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms.
    Desouki MM; Post GR; Cherry D; Lazarchick J
    Clin Med Res; 2010 Jul; 8(2):84-8. PubMed ID: 20660931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].
    Chen DB; Wang Y; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):376-81. PubMed ID: 22932404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A large single-institution retrospective analysis of aggressive B-cell lymphomas according to the 2016/2017 WHO classification.
    Jesionek-Kupnicka D; Braun M; Robak T; Kuncman W; Kordek R
    Adv Clin Exp Med; 2019 Oct; 28(10):1359-1365. PubMed ID: 31518494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The classification of lymphomas and leukemias.
    Ottensmeier C
    Chem Biol Interact; 2001 Jun; 135-136():653-64. PubMed ID: 11397419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin Lymphoma and Its Differential Diagnosis: New Twists on an Old Challenge.
    Sohani AR
    Surg Pathol Clin; 2023 Jun; 16(2):287-346. PubMed ID: 37149361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J
    Ann Oncol; 2000; 11 Suppl 1():3-10. PubMed ID: 10707771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms.
    Medeiros LJ; Chadburn A; Natkunam Y; Naresh KN;
    Mod Pathol; 2024 Apr; 37(4):100441. PubMed ID: 38309432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Practical Approach to Diagnosis of B-Cell Lymphomas With Diffuse Large Cell Morphology.
    King JF; Lam JT
    Arch Pathol Lab Med; 2020 Feb; 144(2):160-167. PubMed ID: 31990228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
    Kovrigina AM; Probatova NA
    Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.